New: FCF Assistant

We’re testing a new AI assistant to help patients, caregivers, and researchers find information faster. Click the FCF Assistant button in the lower right corner to try it.

Skip to content

About Us
News & Media
- Announcements
- Press Releases
For Researchers

About Fibro
Treatments
Research
Resources & Events
Glossary of terms
Clinical Trials
Join the Fight
Giving

About Fibro
Treatments
Research
Resources & Events
Glossary of terms
Clinical Trials
Join the Fight
Giving

Publications by Sarah Schroeder

Home » Research Authors » Publications by Sarah Schroeder

Publications by Sarah Schroeder

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Get In Touch

20 Horseneck Lane
2nd Floor
Greenwich, CT 06830

(203) 340-7800

info@fibrofoundation.org

Recent Posts

Paper published by Washington and New York research teamsApril 22, 2026
New Clinical Guidelines for FLC publishedMarch 31, 2026
Groundbreaking FLC Vaccine Study Published in Nature MedicineNovember 25, 2025

About FCF

This site does not provide medical advice, diagnosis, or treatment. FCF is a 501 (c) (3) tax exempt public charity.

Contact Us
Terms and Conditions
Privacy Policy
Donor Privacy Policy
Gift Acceptance Policy
AI Use Policy

2026 © Fibrolamellar Cancer Foundation